VJHemOnc Podcast cover image

Myeloma 2017 day 2 highlights: MRD, targeted therapies and imaging advances

VJHemOnc Podcast

CHAPTER

Introduction

This chapter covers the impact of MRD on clinical trials, promising targeted therapies, advances in imaging, and the future of drug screening in multiple myeloma. Speakers emphasize the significance of MRD as a prognostic factor and a potential new endpoint in trials.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner